-
-
-
-
-
-
-
Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics
-
-
-
-
-
-
-
Brooklyn ImmunoTherapeutics (BTX) acquires exclusive license for mRNA gene editing and cell therapies technology
-
-
-
-
-
-
-
NTN Buzztime (NTN) Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger
-
-
-
-
-
-
-
BioTime Announces Closing of Acquisition of Asterias Biotherapeutics Creating Leading Cell Therapy Company
-
-
-
-
-
-
-
BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech Showcase
-
-
-
-
-
-
-
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
-
-
-
-
-
-
-
Asterias Biotherapeutics Announces Top Leadership Transition
-
923,759 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All